These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14678064)

  • 21. The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
    Cole JC; Goudie AJ; Field M; Loverseed AC; Charlton S; Sumnall HR
    Drug Alcohol Depend; 2008 Apr; 94(1-3):183-90. PubMed ID: 18201842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial correlates of substance use among adolescents in Mersin, Turkey.
    Tot S; Yazici K; Yazici A; Metin O; Bal N; Erdem P
    Public Health; 2004 Dec; 118(8):588-93. PubMed ID: 15530940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of using answer sheets on reported drug use and data quality in a classroom survey: A cluster-randomized study.
    Castillo-Carniglia A; Pizarro E; Marín JD; Rodríguez N; Casas-Cordero C; Cerdá M
    Drug Alcohol Depend; 2017 Sep; 178():194-200. PubMed ID: 28654872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the prevalence of Ecstasy use among juvenile offenders.
    Yacoubian GS; Arria AM; Fost E; Wish ED
    J Psychoactive Drugs; 2002; 34(2):209-13. PubMed ID: 12691211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecstasy use and its association with sexual behaviors among drug users in New York City.
    Novoa RA; Ompad DC; Wu Y; Vlahov D; Galea S
    J Community Health; 2005 Oct; 30(5):331-43. PubMed ID: 16175956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
    Topp L; Barker B; Degenhardt L
    Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-ingestion of energy drinks with alcohol and other substances among a sample of people who regularly use ecstasy.
    Peacock A; Sindicich N; Dunn M; Whittaker E; Sutherland R; Entwistle G; Burns L; Bruno R
    Drug Alcohol Rev; 2016 May; 35(3):352-8. PubMed ID: 26424666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lifetime tobacco, alcohol and drug use on psychological and behavioral problems among 10th grade students in Istanbul.
    Evren C; Evren B; Bozkurt M; Ciftci-Demirci A
    Int J Adolesc Med Health; 2015 Nov; 27(4):405-13. PubMed ID: 25460280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of illicit drug use among youth: results from the Australian School Students' Alcohol and Drugs Survey.
    Lynskey M; White V; Hill D; Letcher T; Hall W
    Aust N Z J Public Health; 1999 Oct; 23(5):519-24. PubMed ID: 10575775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the temporal relationship between race and ecstasy use among high school seniors.
    Yacoubian GS
    J Drug Educ; 2002; 32(3):213-25. PubMed ID: 12379052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Young adults' recreational social environment as a predictor of ecstasy use initiation: findings of a population-based prospective study.
    Smirnov A; Najman JM; Hayatbakhsh R; Wells H; Legosz M; Kemp R
    Addiction; 2013 Oct; 108(10):1809-17. PubMed ID: 23668641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways between ecstasy initiation and other drug use.
    Martins SS; Ghandour LA; Chilcoat HD
    Addict Behav; 2007 Jul; 32(7):1511-8. PubMed ID: 17174036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial.
    Champion KE; Newton NC; Stapinski LA; Teesson M
    Addiction; 2016 Aug; 111(8):1396-405. PubMed ID: 26880476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mental disorders in ecstasy users: a prospective-longitudinal investigation.
    Lieb R; Schuetz CG; Pfister H; von Sydow K; Wittchen H
    Drug Alcohol Depend; 2002 Oct; 68(2):195-207. PubMed ID: 12234649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Ecstasy use and predisposing factors among Iranian female high school students.
    Shamshiri Milani H; Abadi AR; Helmzadeh Z; Abachizadeh K
    J Pak Med Assoc; 2011 Jun; 61(6):566-71. PubMed ID: 22204212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cluster randomised controlled trial of the Climate Schools: Ecstasy and Emerging Drugs Module in Australian secondary schools: study protocol.
    Champion KE; Teesson M; Newton NC
    BMC Public Health; 2013 Dec; 13():1168. PubMed ID: 24330505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting ecstasy use among young people at risk: a prospective study of initially ecstasy-naive subjects.
    Vervaeke HK; Benschop A; van den Brink W; Korf DJ
    J Drug Educ; 2008; 38(2):131-46. PubMed ID: 18724654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.